Showing results (21-30 of 58) with videos related to
Sort By:
Pageof 6
Pharmacoepidemiology and Drug Safety|December 7, 2019
The role of prescription drugs in female overactive bladder syndrome-A population-wide cohort studyWolfgang Umek, Andreas Gleiss, Barbara Bodner-Adler, et al.Calcified Tissue International|September 19, 2019
Treatment Effects of Bisphosphonates and Denosumab on Survival and Refracture from Real-World Data of Hip-Fractured PatientsMartina Behanova, Berthold Reichardt, Tanja A Stamm, et al.Bone Reports|April 18, 2019
Higher dose but not low dose proton pump inhibitors are associated with increased risk of subsequent hip fractures after first hip fracture: A nationwide observational cohort studyWolfgang Brozek, Berthold Reichardt, Jochen Zwerina, et al.Nature Communications|August 1, 2019
Country-wide medical records infer increased allergy risk of gastric acid inhibitionGalateja Jordakieva, Michael Kundi, Eva Untersmayr, et al.Bone|July 2, 2022
Dispensing anti-osteoporotic drugs changed during the COVID-19 pandemicRoland Kocijan, Theresa Stockinger, Judith Haschka, et al.Journal of Clinical Medicine|May 28, 2022
Pelvic Fractures-An Underestimated Problem? Incidence and Mortality Risk after Pelvic Fracture in Austria, 2010-2018Martina Behanova, Judith Haschka, Berthold Reichardt, et al.Applied Health Economics and Health Policy|December 25, 2014
Potential savings in prescription drug costs for hypertension, hyperlipidemia, and diabetes mellitus by equivalent drug substitution in Austria: a nationwide cohort studyGeorg Heinze, Milan Hronsky, Berthold Reichardt, et al.European Journal of Endocrinology|February 25, 2021
The doubled burden of diabetic bone disease: hip fracture and post-hip fracture mortalityMartina Behanova, Judith Haschka, Jochen Zwerina, et al.BMC Oral Health|November 20, 2022
Antibiotic prescription after tooth extraction in adults: a retrospective cohort study in AustriaSafoura Sheikh Rezaei, Brigitte Litschauer, Karolina Anderle, et al.Rheumatology International|May 19, 2022
Cardiovascular risk and mortality in patients with hyperuricemia treated with febuxostat or allopurinol: a retrospective nation-wide cohort study in Austria 2014-2017Stefan Weisshaar, Brigitte Litschauer, Berthold Reichardt, et al.Pageof 6